• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Previon, Spectrum Solutions Partner to Deliver At-Home COVID-19 Test

    NTT Research, Japanese Entity to Collaborate on Cardiovascular Disease Interventions

    Global Peripheral Intravenous Catheter Market to Reach $7.5 Billion by 2027

    SpinTech Inc. Acquires MR Innovations

    Millstone Medical Outsourcing Reaches 600-Employee Milestone
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Rethink Your Medtech ASC Strategy, Part 1

    Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

    Tips for Reigniting Your MDR/IVDR Preparation

    Three Major Innovation Opportunities for Biomedical Textiles

    Use Vertical Integration to Increase Productivity, Drive Innovation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    maxon

    Concise Engineering

    FUTEK Advanced Sensor Technology Inc.

    PTI Engineered Plastics Inc.

    Spectrum Plastics Group
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Taking the First Step with Metal Components

    4 Trends Driving Medical Manufacturing in 2021

    Pioneering AI Solutions to Reinforce Healthcare Services

    The 8 Major Types of PPE Supply Chain Fraud

    Evolving Trends in the Medical and Orthopedic Devices Industry
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    FUTEK Advanced Sensor Technology Inc.

    Spectrum Plastics Group

    Qosina Corp.

    K-Tube Technologies

    Medicoil
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    The Current COVID-19 Environment and Emergency Use Authorizations

    This column will provide information related to FDA EUAs granted due to the global COVID-19 pandemic.

    Related CONTENT
    • Will Industry’s COVID-19 Recovery End Prematurely?
    • COVID Community: How the Pandemic Is Bringing Out the Best in Us
    • OralDNA Labs Gains EUA for Saline Oral Rinse COVID-19 RT-PCR Test
    • BD's SARS-CoV-2 Antigen Test OKed in Europe
    • Saliva Tests Could Spot Silent COVID-19 Carriers
    Christine Scifert and Dawn Norman, M.S., MRC-X LLC10.01.20
    This column will provide information related to U.S. Food and Drug Administration (FDA) Emergency Use Authorizations (EUAs) granted due to the global COVID-19 pandemic. The current public health threat has justified implementing emergency use authorization for diagnostic, non-diagnostic, and therapeutic medical devices used to detect and/or diagnose COVID-19. Such authorizations have helped make important medical products available more quickly, particularly during shortages of approved and available alternative devices such as personal respiratory protective gear and in-vitro diagnostics.

    COVID-19 is not the first public health emergency where EUAs have been issued but it is by far the most extensive. EUAs were also issued for Zika Virus, the 2014 Ebola Virus, and the 2013 H7N9 Influenza, allowing alternative assay testing for faster detection. FDA can use its EUA authority to allow the use of unapproved medical devices or unapproved uses of approved medical devices to diagnose and treat COVID-19. These authorizations are not subject to specific regulatory requirements during the public health emergency but there are restrictions to the use and labeling requirements imposed on these devices. The next section of this column details the device types that have received this authorization.

    Scope of Devices for EUA
    Medical device types in which EUAs may apply may be found in one of the following categories:
    • In-vitro diagnostic products, high complexity molecular-based tests, and SARS-CoV-2 antibody tests to detect parts of the virus, antibodies, or the biomarkers related to COVID-19-related inflammation
    • Personal protective equipment, such as protective clothing, surgical and non-surgical gowns, helmets, gloves, face shields, intubation shields, goggles, respirators, or other equipment designed to protect people from the spread of COVID-19
    • Ventilators and respiratory assistance devices, and devices used for their decontamination to control and support patient breathing and allowing for reuse of certain respirators in short supply
    • Blood purification and continuous renal replacement therapy and hemodialysis devices to help reduce small active proteins in the bloodstream, which are typically elevated during infections and lead to more severe reactions. These products help to filter and clean blood when the kidneys are not functioning normally
    • Infusion pumps, and remote or wearable patient monitoring devices to help increase the availability of devices delivering controlled levels of fluids and medications, or for monitoring and treating patients to help reduce viral exposure to healthcare providers

    Enforcement Discretion—Product-Specific and Quality System
    Medical device classification and potential risk determines the regulatory pathway and requirements for devices. For example, Class I devices such as face shields have a more broad set of requirements for EUA as opposed to more specific guidance and requirements for higher risk and class devices. Guidance for these lower risk devices also provides allowances where they are not subject to the following regulatory requirements in some cases:
    • Registration and Listing requirements in 21 CFR 807
    • Quality System Regulation requirements in 21 CFR 820
    • Reports of corrections and removals in 21 CFR Part 806
    • Unique Device Identification requirements in 21 CFR Part 830 and 21 CFR 801.20
    Other requirements typical for manufacturers persist, such as reporting of adverse events (via MDR), device history records, and distribution or traceability records with the possibility that additional information related to the device may be requested by the FDA.

    Additional labeling requirements apply to the manufacturers and distributors of these authorized products; for example, face shields must identify the device as single-use or for use by a single user and include instructions for cleaning and/or disinfection if applicable. Advertising or promotional materials cannot suggest the product is safe or effective for the prevention or treatment of patients during the COVID-19 pandemic and shall clearly identify that the product has not been FDA approved and is only authorized for use only during declaration of the EUA.

    In contrast with exemptions from regulatory requirements allowable for Class I devices, Class II devices are not exempt from 21 CFR 806 (reports of corrections or removals) or 21 CFR 820 (Quality System Regulation requirements).

    The exemptions for EUA devices will again be enforced after the public health emergency is over. It is currently impossible to determine when the health emergency will conclude. Therefore, plans should be made to address each of the previously mentioned excluded requirements if there is a desire to continue marketing the device long-term.

    Timelines and Long-Term Planning
    Once the exemptions for EUA devices end, manufacturers will have to comply with FDA regulations. Depending on the device classification, it will be important to have a plan in place for the following:
    • Registration and Listing requirements in 21 CFR 807, where manufacturers are required to register their facility and list each product sold. This establishment registration fee is $5,236 for Fiscal Year 2020.
    • Quality System Regulation requirements in 21 CFR 820, where the quality system regulation governs the methods used in, and the facilities and controls used for the design, manufacture, packaging, labeling, storage, installation, and servicing of all finished devices intended for human use.
    • Reports of corrections and removals in 21 CFR 806, where manufacturers are required to promptly report certain actions concerning device corrections and removals (recalls), and to maintain records of corrections and removals.
    • Unique Device Identification requirements in 21 CFR Part 830 and 21 CFR 801.20, where the label of every medical device must bear a unique device identifier (UDI) registered with FDA through the Global Unique Device Identification Database (GUDID).
    Additionally, the possibility of revocation for an EUA exists and could occur unexpectedly. One example that recently occurred is related to protective barrier enclosures without negative pressure, typically used for intubation. There is the possibility this will set precedence and revocation of EUAs are going to continue as additional data comes forward about the safety and effectiveness of certain EUA devices where there is a perceived increased risk to patients and health care providers. FDA made its decision based on evidence in simulated intubation procedure models recently reported in literature.1,2

    Conclusion
    Manufacturers must comply with the current EUA requirements before distributing products. In addition, these manufacturers are subject to FDA enforcement discretion due to EUAs and if they want to continue marketing these devices, they must be prepared to comply to all regulations and requirements. These requirements can include registration and listing, quality system regulation, reporting of corrections and removals, or UDI requirements when the COVID-19 public health emergency concludes. These considerations pertain only to the U.S. market and FDA. 

    References
    1. Simpson J.P, et al., Measurement of airborne particle exposure during simulated tracheal intubation using various proposed aerosol containment devices during the COVID-19 pandemic, Anesthesia, 19 June 2020, 1-9.
    2. Begley J.I. et al., The Aerosol box for intubation in COVID-19 patients: an in-situ simulation crossover study, Anesthesia, August 20202. 75 (8), 1014-1021.


    Christine Scifert is co-founder of MRC-X LLC (previously Memphis Regulatory Consulting LLC), which offers medical device regulatory, quality and clinical services. Prior to MRC Global, Scifert spent 11 years as a consultant with MRC-X LLC and Memphis Regulatory Consulting and nine years at Medtronic Spinal and Biologics directing the regulatory department of 22 people. As senior director, she set regulatory strategy, oversaw global submissions and developed a design control process. Prior to Medtronic, Scifert performed evaluations of injury mechanisms associated with automobile collisions, slip and falls, and sport/recreation accidents. Scifert earned a bachelor of science degree in physics from Hamline University and a masters of science degree in biomedical engineering from University of Iowa. She also completed a master’s degree in engineering management from Christian Brothers University. Scifert is also an adjunct professor at Christian Brothers University teaching regulatory affairs and presents nationally as a regulatory expert at various industry events.

    Prior to MRC Global, Dawn Norman spent 15 years in the medical device industry working with venture capital backed startups and larger companies alike. She focused on regulatory strategy and submissions, along with clinical study design and study execution. Norman was directly involved with early development and market entry for leading-edge medical innovation including magnetic navigation devices for neurosurgical, neurovascular and cardiac indications, high intensity ultrasound for cardiac ablation, recombinant proteins for bone fusion, orthopedic trauma, infusion pumps, and advanced imaging technologies. Norman earned a bachelor of arts degree in biological sciences and chemistry, and a masters of science degree in biomedical sciences from Southern Illinois University at Edwardsville.  She is also a certified ISO 13485 lead auditor. Norman is an industry expert and presents at various trade shows/conferences.
    Suggested For You
    Will Industry’s COVID-19 Recovery End Prematurely? Will Industry’s COVID-19 Recovery End Prematurely?
    COVID Community: How the Pandemic Is Bringing Out the Best in Us COVID Community: How the Pandemic Is Bringing Out the Best in Us
    OralDNA Labs Gains EUA for Saline Oral Rinse COVID-19 RT-PCR Test OralDNA Labs Gains EUA for Saline Oral Rinse COVID-19 RT-PCR Test
    BD BD's SARS-CoV-2 Antigen Test OKed in Europe
    Saliva Tests Could Spot Silent COVID-19 Carriers Saliva Tests Could Spot Silent COVID-19 Carriers
    Cepheid Cepheid's Combo COVID-19, Flu A/B, RSV Test Earns EUA
    Hologic Granted EUA for Asymptomatic COVID-19 Testing Hologic Granted EUA for Asymptomatic COVID-19 Testing
    75-Minute Diagnostic Determines COVID Status 75-Minute Diagnostic Determines COVID Status
    Vela Diagnostics Vela Diagnostics' SARS-CoV-2 RT-PCR Test v2.0 Earns EUA
    TEAM Technologies Partners with Maxim Biomedical TEAM Technologies Partners with Maxim Biomedical
    FDA Authorizes First Point-of-Care COVID-19 Antibody Test FDA Authorizes First Point-of-Care COVID-19 Antibody Test
    Eurobio Scientific Launches Rapid Dx Test for SARS CoV-2 Virus Antigen Eurobio Scientific Launches Rapid Dx Test for SARS CoV-2 Virus Antigen
    UK Study Reveals the Accuracy of a 90-Minute COVID-19 Test UK Study Reveals the Accuracy of a 90-Minute COVID-19 Test
    Rapid Test for COVID-19 Shows Improved Sensitivity Rapid Test for COVID-19 Shows Improved Sensitivity
    COVID-19 Molecular Test Shipments Exceed 150 Million COVID-19 Molecular Test Shipments Exceed 150 Million

    Related Columns

    • Surgical
      Rethink Your Medtech ASC Strategy, Part 1

      Rethink Your Medtech ASC Strategy, Part 1

      ASCs have adopted a strategy to focus on predictable, low-risk procedures with lower complication rates in an out-of-hospital setting.
      Maria Shepherd, President and Founder, Medi-Vantage 02.03.21

    • R&D & Design
      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic restrictions may have diminished certain advantages large companies hold over small and mid-sized competitors.
      Dawn A. Lissy, President & Founder, Empirical 02.03.21

    • Tips for Reigniting Your MDR/IVDR Preparation

      Tips for Reigniting Your MDR/IVDR Preparation

      To get the MDR/IVDR preparation ball rolling again, here are four processes to help refocus on achieving compliance with the updated regulations.
      Nicolle Cannon, Founder and CEO, Cannon Quality Group LLC 02.03.21


    • Materials
      Three Major Innovation Opportunities for Biomedical Textiles

      Three Major Innovation Opportunities for Biomedical Textiles

      Biomedical textiles are gaining significant momentum for use in medical devices to facilitate less invasive surgical procedures.
      John Greco, Vice President of Sales, Cortland Biomedical 02.03.21

    • Contract Manufacturing
      Use Vertical Integration to Increase Productivity, Drive Innovation

      Use Vertical Integration to Increase Productivity, Drive Innovation

      The concept of vertical integration is simple: a company combining two or more stages of production that would normally be operated by separate companies.
      Ryan Lipe, Senior Vice President of Sales & Marketing, MGS 02.03.21

    • How to Better Prepare for Regulatory Requests and Minimize Impact

      How to Better Prepare for Regulatory Requests and Minimize Impact

      Pressure to increase efficiency in medical device development has been prevalent over the past year, especially with the intensified regulatory expectations.
      Sandi Schaible, Sherry Parker and Kim Ehman, WuXi AppTec Medical Device Testing 02.03.21


    • C-Suite Challenges in Medtech’s New Normal

      C-Suite Challenges in Medtech’s New Normal

      Many of the usual C-Suite management topics that are key to organizational success will remain the same this year.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 02.03.21

    • COVID-19: Accelerator of a Modern, Data-Driven Supplier Strategy

      COVID-19: Accelerator of a Modern, Data-Driven Supplier Strategy

      By the time COVID-19 arrived in the United States, global supply chains were already buckling under a historic level of demand.
      Denise Odenkirk, Vice President, Supplier Sales, Global Healthcare Exchange LLC 02.03.21

    • Fixing Face Mask Form and Function

      Fixing Face Mask Form and Function

      Masks for the general public are varied in both style and effectiveness.
      Sam Brusco, Associate Editor 11.04.20


    • Cardiovascular
      The Heart of the Matter: Trends in Cardiology

      The Heart of the Matter: Trends in Cardiology

      Of the three major segments of coronary stents, bioabsorbable stents are expected to have the highest growth between now and 2022.
      Maria Shepherd, President and Founder, Medi-Vantage 11.04.20

    • Virtually the Same? The Challenges of Online Conferences

      Virtually the Same? The Challenges of Online Conferences

      Like everyone else on the planet, I’m turning increasingly to virtual solutions to our physical challenges in the midst of a pandemic.
      Dawn A. Lissy, Founder & President, Empirical 11.04.20

    • Digital Health
      Digital Health Delivers During a Year for the Ages

      Digital Health Delivers During a Year for the Ages

      Internet of Medical Things technologies have emerged as the key enabler of a much more holistic and complete disease-state management toolbox.
      Brad Womble, Senior Director of Strategy, Marketing, and Mergers & Acquisitions, Jabil Healthcare 11.04.20


    • Advanced Technology for Staking and Swaging Medical Plastics

      Advanced Technology for Staking and Swaging Medical Plastics

      It reliably assembles heat- and vibration-sensitive components, and works with a wide range of plastic materials.
      Priyank Kishor, Global Product Manager—PulseStaking, Branson at Emerson 11.04.20

    • Quality Assurance When Supply Chain Disruptions Arise

      Quality Assurance When Supply Chain Disruptions Arise

      From supply chain disruptions to impromptu manufacturing modifications, the medical device industry has faced a whirlwind of complications in 2020.
      Sandi Schaible and Peter Steen, WuXi AppTec Medical Device Testing 11.04.20

    • The Top 30 and M&A in 2021: What’s Next?

      The Top 30 and M&A in 2021: What’s Next?

      With three of the top five companies appointing new CEOs in the last year and the global pandemic eroding earnings, M&A strategies could look a lot different.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 11.04.20


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • Top 10 Trends In The Medical Device And Equipment Industry
    • 7 Considerations For Designing Medical Device Mechanisms
    • FDA Approves Daytime Treatment For Sleep Apnea And Snoring
    Breaking News
    • Previon, Spectrum Solutions Partner to Deliver At-Home COVID-19 Test
    • NTT Research, Japanese Entity to Collaborate on Cardiovascular Disease Interventions
    • Global Peripheral Intravenous Catheter Market to Reach $7.5 Billion by 2027
    • SpinTech Inc. Acquires MR Innovations
    • Millstone Medical Outsourcing Reaches 600-Employee Milestone
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • Seeking a Revolution in Clinical Care Through AI
    • Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit
    • Addition by Subtraction: The Latest of Machining for Medtech
    • Innovation Incubators: An R&D Roundtable
    • Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula
    JRF Technology Debuts Elderberry Oral Film Strip
    Danone Adds to Plant-Based Portfolio with Acquisition of Follow Your Heart Brand
    Coatings World

    Latest Breaking News From Coatings World

    Hempel Launches Sustainability Framework: Futureproof
    ChemQuest Hires Rich Gibson
    New Increase in Kynar Fluoropolymer Capacities at Arkema's Chinese Site
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Previon, Spectrum Solutions Partner to Deliver At-Home COVID-19 Test
    NTT Research, Japanese Entity to Collaborate on Cardiovascular Disease Interventions
    Global Peripheral Intravenous Catheter Market to Reach $7.5 Billion by 2027
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement
    Pfizer Selects Seven Bridges to Support RNA Sequencing Data
    ACG Launches ACG Laboratories
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Afro Sheen Launches New Brand Initiatives
    Neopac Introduces Lightweight Plastic Tube
    Estée Lauder Companies Increases Investment in Deciem Beauty Group Inc.
    Happi

    Latest Breaking News From Happi

    PBA Opposes House Bill 2325 in West Virginia
    J.R. Watkins Tackles Pain with New Lines
    RB Launches Vanish Miracle
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Lowe-Martin Adds 2 KODAK NEXFINITY Digital Presses
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Eaglewood Technologies debuts new anilox cleaning system
    INX International and VerifyMe sign supply agreement
    Soma partners with DTM Flexo Services
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Fiber Bond VE3 Technology Inactivates SARS-CoV-2 in HVAC Filtration Systems
    Citizens Provides $325 Million Senior Credit Facility to Nice-Pak
    Ontex Reports Lower Revenues
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OrthoGrid Releases New Hip Replacement Software
    Nexus Spine Announces Availability of Spine Surgery Implants
    FDA OKs Brainlab's Loop-X Mobile Imaging Robot, Cirq Robotic Alignment Module
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    RFID Locks Market to Reach $9.93 Billion by 2027: Allied Market Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login